Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer

PURPOSE: To address demands for timely germline information to guide treatments, we evaluated experiences of patients with ovarian, pancreatic, and prostate cancer with a mainstreaming genetic testing model wherein multigene panel testing was ordered by oncologists with standardized pre-test patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamilton, Jada G., Symecko, Heather, Spielman, Kelsey, Breen, Kelsey, Mueller, Rebecca, Catchings, Amanda, Trottier, Magan, Salo-Mullen, Erin E., Shah, Ibrahim, Arutyunova, Anna, Batson, Melissa, Gebert, Rebecca, Pundock, Stacy, Schofield, Elizabeth, Offit, Kenneth, Stadler, Zsofia, Cadoo, Karen, Carlo, Maria I., Narayan, Vivek, Reiss, Kim A., Robson, Mark E., Domchek, Susan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556289/
https://www.ncbi.nlm.nih.gov/pubmed/34257420
http://dx.doi.org/10.1038/s41436-021-01262-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556289/
https://www.ncbi.nlm.nih.gov/pubmed/34257420
http://dx.doi.org/10.1038/s41436-021-01262-2

Ejemplares similares